pharmaphorum

SEPTEMBER 20, 2021

The approval comes a few weeks after the biosimilar was cleared for marketing in the EU with a broader label, as it also includes diabetic macular oedema (DMO), another of Lucentis’ approved indications. Sales reached a peak in 2019, when Roche booked $1.8 billion in sales from the drug while Novartis made $2.1 billion and $1.9

Biosimilars 72

Biosimilars Labelling Diabetes 72

Big Molecule Watch

JUNE 7, 2024

FDA approves first interchangeable biosimilars to EYLEA (aflibercept) to treat macular degeneration and other eye conditions Regeneron’s regulatory exclusivity for EYLEA expired on May 18, 2024. Two days later, on May 20, 2024, the FDA announced that it has approved Mylan Pharmaceuticals, Inc. and Biocon Biologics, Inc.’s 11,084,865.”

Biosimilars 40

Biosimilars Diabetes Labelling 40

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Biosimilars 52

Biosimilars Labelling Diabetes Compounding 52

Quality Matters

SEPTEMBER 9, 2024

The area is populated with apps and other software designed to treat various ailments including mental health disorders, diabetes, asthma, insomnia, substance-use disorders, and beyond. billion in 2024 to over 32 billion in 2030. Patients can often use them from the comfort of their homes.

Labelling 52

Labelling Diabetes 52

RX Note

AUGUST 25, 2024

I heard fenugreek is helpful for diabetes management. FDA requires the labels of all herbal supplements to include the complete list of ingredients and manufacturers must follow good manufacturing practices (GMP) to ensure that supplements are processed consistently and meet quality standards. Is that true?

Diabetes 52

Diabetes Community Pharmacies Dosage Documentation 52

Putting Patients First Blog

JULY 2, 2024

Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. Off-label usage often emerges from real- world clinical practice and patient experiences, which might not be reflected in the guidelines. Sincerely, Randall L.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

PharmaShots

MAY 3, 2023

Eli Lilly Launches Rezvoglar as Second Interchangeable Insulin Biosimilar in the US Date- April 01, 2023 Product: Rezvoglar The company launched Rezvoglar, a second interchangeable biosimilar insulin product to Lantus (insulin glargine) in the US market for the treatment of patients with diabetes. Infections were observed in 33.9%

Biosimilars 56

Biosimilars Labelling Diabetes 56

PharmaShots

APRIL 3, 2023

old, for use by women with diabetes who are pregnant & for wear time of up to 15 days. The results also showed a reduction in risk of hospitalization for any cause with 14% relative risk reduction (24.8 events/100 patient-yrs.) 4 approved medicines across solid tumors & hematologic malignancies, incl.

Biosimilars 40

Biosimilars Diabetes Compounding Hospitals 40

Putting Patients First Blog

JANUARY 27, 2025

3 ,4, 5 As such, the NHC supports CMS proposal to ensure that Part D sponsors cover AOMs for obesity with clinical criteria that is not more restrictive than the FDA labeling for each AOM. 19 National Health Council, National Health Council 2024 Public Policy Issue Areas Survey (internal survey, Policy & Government Affairs, 2023).

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

The Thyroid Pharmacist

NOVEMBER 15, 2024

There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.

Diabetes 75

Diabetes Immunity Immunization Compounding 75

RX Note

DECEMBER 25, 2024

Strategies for sodium reduction include Make reading food labels a habit. WebMD - Celtic Salt: What You Should Know, 2024 Should you use iodized salt?, Almost all national and international organizations recommend dietary sodium reduction as part of the nonpharmacologic therapy for hypertension.

Community Pharmacies 40

Community Pharmacies Packaging Labelling Diabetes 40

The Thyroid Pharmacist

DECEMBER 27, 2024

I cant believe that its been over 10 years since I started the thyroidpharmacist.com blog in 2013, and now 2024 is almost over. New Articles in 2024 Why Thyroid Antibodies Matter : This article was very important to me, as Ive heard medical professionals say that thyroid antibodies dont matter! Wow do the years just fly by!

Labelling 67

Labelling Diabetes 67